UNSPSC 51282605: Cefozopran

This classification denotes a cephalosporin antibiotic with the molecular formula C19H17N9O5S2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 1LG87K28LW, chemically known as imidazo(1,2-b)pyridazinium, 1-((7-(((5-amino-1,2,4-thiadiazol-3-yl)(methoxyimino)acetyl)amino)-2-carboxy-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-3-yl)methyl)-, inner salt, (6r-(6alpha,7beta(z)))- but generally known as cefozopran, which bears US NIH Compound Identifier 9571080.

UNSPSC 51282605 Cefozopran, a Commodity code, nominally designates a specific injectable antibiotic; however, recent state and local solicitations tagged with this code do not reflect procurement of cefozopran itself. Instead, the opportunities posted under it span pharmaceuticals, over-the-counter medical products, and pharmacy benefit administration across a wider range of drug classes and supply categories. State and local governments are using this code to solicit multi-source generic pharmaceuticals, naloxone and drug deactivation systems, medical and first aid supplies for emergency response, and pharmacy benefit program infrastructure—indicating either a tagging misalignment or a broadened application of the code to pharmaceutical procurement at the commodity level. Issuing bodies include state health and human services commissions, county public health departments, city fire rescue divisions, and statewide cooperative purchasing alliances that serve multiple government jurisdictions. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) and the City of Tampa have been active solicitors, with Texas Health and Human Services Commission pursuing exploratory market intelligence on direct-to-manufacturer prescription programs.

Recent activity spans Minnesota, Florida, and Texas. The Minnesota Department of Administration issued an RFP in January 2026 for generic multi-source pharmaceuticals and OTC products distributed across state and local facilities in Minnesota and Oregon, due March 26, 2026, with awards effective July 1, 2026 and a two-year term. The City of Tampa released an IFB in March 2026 for 169 line items of medical and first aid supplies for the Fire Department Rescue Division, due March 13, 2026, estimated at $700,000 and sheltered for certified Small Local Business Enterprises with a 5% bid discount. Seminole County, Florida posted an IFB in June 2026 for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries, due July 26, 2023. The Texas Health and Human Services Commission issued an RFI in April 2026 to gather vendor capabilities on direct-to-manufacturer prescription programs for self-insured employee health plans and state agencies, with responses due April 3, 2026. The code shows fragmented activity across different pharmaceutical and medical supply categories rather than concentrated cefozopran-specific procurement.